Pre-Operative Chemoradiation Followed by Post-Operative Tetrathiomolybdate (TM) in Patients With Loco-Regional Esophageal Carcinoma (UMCC 2001-007)
Phase of Trial: Phase II
Latest Information Update: 14 Jan 2019
At a glance
- Drugs Tetrathiomolybdate (Primary)
- Indications Carcinoma; Oesophageal cancer
- Focus Therapeutic Use
- 12 Aug 2016 Status changed from active, no longer recruiting to completed.
- 19 Jan 2010 Planned end date changed from 1 Nov 2009 to 1 Nov 2015 as reported by ClinicalTrials.gov.
- 13 Dec 2007 Status changed from recruiting to in progress.